ZA96933B - Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines. - Google Patents

Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines.

Info

Publication number: ZA96933B
Authority: ZA; South Africa
Prior art keywords: dioxinopyridines; dihydro; vasoconstrictive; substituted; vasoconstrictive substituted
Prior art date: 1995-02-07

Application number

ZA9600933A

Other languages

English (en)

Inventor

Guy Rosalia Eugene Van Lommen

Jose Ignacio Andres-Gil

Francisco Javi Fernandez-Gadea

Maria Enc Matesanz-Ballesteros

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-07

Filing date

1996-02-06

Publication date

1997-08-06

1996-02-06 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1997-08-06 Publication of ZA96933B publication Critical patent/ZA96933B/xx

Links

QWQZJEXJTYAPGE-UHFFFAOYSA-N 2,3-dihydro-[1,4]dioxino[2,3-b]pyridine Chemical class C1=CC=C2OCCOC2=N1 QWQZJEXJTYAPGE-UHFFFAOYSA-N 0.000 title 1
230000003639 vasoconstrictive effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)

ZA9600933A 1995-02-07 1996-02-06 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines. ZA96933B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP95200290		1995-02-07

Publications (1)

Publication Number	Publication Date
ZA96933B true ZA96933B (en)	1997-08-06

Family

ID=8219997

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9600933A ZA96933B (en)	1995-02-07	1996-02-06	Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines.

Country Status (16)

Country	Link
US (1)	US5990123A (de)
EP (1)	EP0808316B9 (de)
JP (1)	JP4093431B2 (de)
KR (1)	KR100412070B1 (de)
AR (1)	AR002959A1 (de)
AT (1)	ATE263170T1 (de)
AU (1)	AU692361B2 (de)
DE (1)	DE69632032T2 (de)
ES (1)	ES2218582T3 (de)
FI (1)	FI113774B (de)
IL (1)	IL117045A (de)
MY (1)	MY113426A (de)
NO (1)	NO315237B1 (de)
TW (1)	TW446706B (de)
WO (1)	WO1996024596A1 (de)
ZA (1)	ZA96933B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7189753B1 (en)	1997-11-06	2007-03-13	Cady Roger K	Preemptive prophylaxis of migraine
US6656950B2 (en)	2001-04-25	2003-12-02	Wyeth	Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
US6821981B2 (en)	2001-04-26	2004-11-23	Wyeth	Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]-quinoline as 5-HT1A antagonists
WO2004106298A1 (en) *	2003-05-30	2004-12-09	Janssen Pharmaceutica N.V.	Indole derivatives with an improved antipsychotic activity
EP1805142A4 (de) *	2004-09-23	2009-06-10	Reddy Us Therapeutics Inc	Neue pyridinverbindungen, verfahren zu ihrer herstellung und zusammensetzungen damit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1254496B (it) *	1992-03-05	1995-09-25	Enichem Spa	Preparazione di copolimeri alternati olefine/ossido di carbonio per mezzo di un catalizzatore eterogeneo supportato
ZA931343B (en) *	1992-03-06	1993-09-24	Akzo Nv	1,4-dioxino(2,3-b)pyridine derivatives.
DE4226527A1 (de) *	1992-08-11	1994-02-17	Merck Patent Gmbh	1,4-Benzodioxanderivate

1996
- 1996-01-29 TW TW085101041A patent/TW446706B/zh not_active IP Right Cessation
- 1996-01-30 DE DE69632032T patent/DE69632032T2/de not_active Expired - Lifetime
- 1996-01-30 AT AT96903952T patent/ATE263170T1/de not_active IP Right Cessation
- 1996-01-30 JP JP52394996A patent/JP4093431B2/ja not_active Expired - Lifetime
- 1996-01-30 EP EP96903952A patent/EP0808316B9/de not_active Expired - Lifetime
- 1996-01-30 WO PCT/EP1996/000396 patent/WO1996024596A1/en not_active Ceased
- 1996-01-30 KR KR1019970705318A patent/KR100412070B1/ko not_active Expired - Lifetime
- 1996-01-30 ES ES96903952T patent/ES2218582T3/es not_active Expired - Lifetime
- 1996-01-30 US US08/875,835 patent/US5990123A/en not_active Expired - Lifetime
- 1996-01-30 AU AU47856/96A patent/AU692361B2/en not_active Expired
- 1996-02-06 IL IL11704596A patent/IL117045A/xx not_active IP Right Cessation
- 1996-02-06 AR ARP960101287A patent/AR002959A1/es unknown
- 1996-02-06 ZA ZA9600933A patent/ZA96933B/xx unknown
- 1996-02-07 MY MYPI96000448A patent/MY113426A/en unknown
1997
- 1997-08-06 NO NO19973624A patent/NO315237B1/no not_active IP Right Cessation
- 1997-08-06 FI FI973245A patent/FI113774B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI113774B (fi)	2004-06-15
ATE263170T1 (de)	2004-04-15
FI973245A0 (fi)	1997-08-06
IL117045A (en)	1999-03-12
KR19980701921A (ko)	1998-06-25
MY113426A (en)	2002-02-28
AU4785696A (en)	1996-08-27
TW446706B (en)	2001-07-21
JPH10513460A (ja)	1998-12-22
NO315237B1 (no)	2003-08-04
EP0808316A1 (de)	1997-11-26
FI973245L (fi)	1997-08-06
EP0808316B1 (de)	2004-03-31
JP4093431B2 (ja)	2008-06-04
WO1996024596A1 (en)	1996-08-15
EP0808316B9 (de)	2004-12-01
AR002959A1 (es)	1998-05-27
NO973624D0 (no)	1997-08-06
KR100412070B1 (ko)	2004-05-24
IL117045A0 (en)	1996-06-18
DE69632032D1 (de)	2004-05-06
AU692361B2 (en)	1998-06-04
DE69632032T2 (de)	2005-03-10
NO973624L (no)	1997-08-06
US5990123A (en)	1999-11-23
ES2218582T3 (es)	2004-11-16

Publication	Publication Date	Title
ZA967315B (en)	1998-03-02	Biphenylamides.
IL141908A0 (en)	2002-03-10	1,4-benzodiazepine derivatives
PH30894A (en)	1997-12-23	1,5-Benzodiazepine derivative.
MX213417B (es)	2003-03-27	Fenilpiridazinonas.
ZA986358B (en)	2000-01-17	Dolastatin 15 derivatives.
ZA964468B (en)	1997-02-06	Triazolylmethyl-cyclopentanols.
ZA972056B (en)	1997-09-22	Substituted 1,2,3,4-tetrahydronaphthalene derivatives.
ZA961955B (en)	1997-09-11	Indazolecarboxamides.
ZA965418B (en)	1997-12-29	Quick-fermented feed, its preparation and uses.
ZA973984B (en)	1997-11-17	2,4-diaminopyrimidine derivatives.
ZA9710542B (en)	1999-07-23	Modified 1,3-propanediol-based polyesters.
DE69610844D1 (en)	2000-12-07	Hydroformylierungsverfahren.
ZA962753B (en)	1997-10-06	1,3-Dihydro-2H-imidazol-2-one derivatives.
ZA969625B (en)	1997-05-22	25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols
ZA966399B (en)	1997-02-19	Endothelin-receptor-antagonists.
ZA977036B (en)	1998-02-09	Substituted oxadiazine derivatives.
EP0628591A3 (de)	1995-08-02	Subsitiuierte 1.3.5-Triazin-Einheiten enthaltende Organopolysiloxane.
AU4785696A (en)	1996-08-27	Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
ZA986160B (en)	2000-01-10	2,4,4-trisubstituted-1,3-dioxolone antifungals.
ZA966933B (en)	1997-02-19	Endothelin-receptor-antagonists.
ZA966750B (en)	1997-02-18	Halogenobenzimidazoles.
ZA972302B (en)	1997-09-22	1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.
ZA967314B (en)	1998-03-02	Carbamoylcarboxamides.
ZA96977B (en)	1997-08-07	Herbicidal[1,2,4]Thiadiazoles.
ZA984592B (en)	1999-11-29	Herbicidal 3,5-difluoropyridines.